云顶新耀股价升两成 盈利潜力助力估值修复
Oct 18, 2024 18:31 HKT | |
|
雲頂新耀股價升兩成 盈利潛力助力估值修復
Oct 18, 2024 18:28 HKT | |
|
康哲藥業：蘆可替尼乳膏（白癜風）大灣區首批處方落地
Oct 18, 2024 14:54 HKT |  |
|
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells
Oct 17, 2024 08:00 HKT |  |
|
Athos宣布其人工智能生成的全新口服G9A抑制剂ATH-063的I期临床试验顶线数据，显示其对强效抗炎调节性T细胞的选择性扩增和激活
Oct 17, 2024 08:00 HKT | |
|
Athos宣佈其人工智慧生成的全新口服G9A抑製劑ATH-063的I期臨床試驗頂線數據，顯示其對強效抗炎調節性T細胞的選擇性擴增和啟動
Oct 17, 2024 08:00 HKT | |
|
CanSino Receives Another Strong Boost
Oct 09, 2024 19:29 HKT | |
|
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
Sep 25, 2024 21:00 HKT |  |
|
康哲藥業：磷酸蘆可替尼乳膏（白癜風）中國上市許可申請已獲受理
Sep 24, 2024 21:46 HKT | |
|
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Sep 17, 2024 20:30 HKT |  |
|
君聖泰醫藥亮相香港國際生物科技論壇
Sep 17, 2024 15:00 HKT |  |
|
君聖泰醫藥亮相香港國際生物科技論壇
Sep 16, 2024 14:53 HKT | |
|
君圣泰医药亮相香港国际生物科技论坛
Sep 13, 2024 18:22 HKT | |
|
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱（HTD1801）在T2DM中的两项事后分析
Sep 11, 2024 11:51 HKT | |
|
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
Sep 11, 2024 11:34 HKT | |
|
EASD 2024 | 君聖泰醫藥口頭報告熊去氧膽小檗碱（HTD1801）在T2DM中的兩項事後分析
Sep 11, 2024 11:16 HKT | |
|
Hua Medicine Announces 2024 Interim Results
Aug 30, 2024 11:40 HKT | |
|
華領醫藥公佈2024年中期業績
Aug 30, 2024 11:12 HKT | |
|
华领医药公布2024年中期业绩
Aug 30, 2024 09:25 HKT | |
|
CanSinoBIO Reports Outstanding H1 2024 Performance
Aug 29, 2024 22:23 HKT | |
|